2026 Wmif Immunology Inflammation Commercial Potential Clinical Frontiers

Summary

Speakers Meredith Fisher PhD, Partner, Mass General Brigham Ventures (Moderator) Niranjana Nagarajan MSc, PhD, Chief ... Summary Robert Lustig MD moderated a conversation with Bahia Jaffer, Joan LaRovere MD and Carter Williams about a ... Summary David Ting MD moderated a discussion with Adam Kaye, Sandra McAllister PhD, Diarmuid Moran and Rahul Aras PhD ... Summary Patients are already using artificial intelligence to understand symptoms, interpret test results and prepare for ... Summary Solid tumor treatment has progressed through successive waves of chemotherapy, targeted therapy, immunotherapy ... TRACE: Compressing Optimization of Biologics from Years to Weeks Gaurav Gaiha MD, DPhil Associate Professor of Medicine ... Summary The first generation of cell and gene therapies proved that genetic disease can be treated at its source. The next ... Summary RNA interference has moved from a Nobel Prize-winning discovery to a validated drug platform, and John Harris MD, ... Summary American academic medicine's global role is changing. Instead of primarily bringing international patients to the United ... Summary Artificial intelligence is advancing globally, but bringing an AI-enabled healthcare company into the US takes more than ... Speakers Joseph Bonventre MD, PhD, Chief, Division of Engineering in Medicine and Chief Emeritus, Renal Division, Mass ... Speakers Jason Gerberry, US Large Cap Pharma and Specialty Pharma Analyst, BofA Securities (Moderator) Alec Stranahan, US ... Summary Entering the US healthcare market takes more than opening an office or running a pilot. Moderated by Yonatan ... Programmable Anticoagulants: Mitigating Systemic Risk Through Spatial Control Jonathan Carlson MD, PhD Director of ...